87 related articles for article (PubMed ID: 18296707)
1. Re: "plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies".
Meerwaldt R; Links T; Zeebregts C; Smit A
Am J Epidemiol; 2008 Mar; 167(6):756-7. PubMed ID: 18296707
[No Abstract] [Full Text] [Related]
2. Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men.
Wu T; Rifai N; Willett WC; Rimm EB
Am J Epidemiol; 2007 Sep; 166(5):544-51. PubMed ID: 17615090
[TBL] [Abstract][Full Text] [Related]
3. Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies.
Wu T; Willett WC; Rifai N; Rimm EB
Am J Epidemiol; 2007 Sep; 166(5):552-60. PubMed ID: 17615091
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein complexed C-reactive protein in patients with coronary heart disease.
Elmas E; Kälsch T; Borggrefe M; Dempfle CE
Thromb Haemost; 2005 Nov; 94(5):1111-2. PubMed ID: 16363260
[No Abstract] [Full Text] [Related]
5. Does C-reactive protein represent an oxidative stress marker in cardiovascular disease?
Korantzopoulos P; Papaioannides D; Galaris D; Kokkoris S
Int J Clin Pract; 2003 Apr; 57(3):252. PubMed ID: 12723737
[No Abstract] [Full Text] [Related]
6. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
7. The role of inflammation for heart disease risk cannot be determined by correlations between C-reactive protein and risk factors.
Engström G
Arch Intern Med; 2006 May; 166(9):1040; author reply 1040-1. PubMed ID: 16682580
[No Abstract] [Full Text] [Related]
8. Effects of alcohol-free beer on lipid profile and parameters of oxidative stress and inflammation in elderly women.
Martínez Alvarez JR; Bellés VV; López-Jaén AB; Marín AV; Codoñer-Franch P
Nutrition; 2009 Feb; 25(2):182-7. PubMed ID: 18947976
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein in healthy and in sick populations.
Danesh J; Pepys MB
Eur Heart J; 2000 Oct; 21(19):1564-5. PubMed ID: 10988004
[No Abstract] [Full Text] [Related]
10. C-reactive protein, heart disease risk, and the popular media.
Tracy RP; Kuller LH
Arch Intern Med; 2005 Oct; 165(18):2058-60. PubMed ID: 16216994
[No Abstract] [Full Text] [Related]
11. C-reactive protein and coronary heart disease.
Libby P; Willerson JT; Braunwald E
N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257564
[No Abstract] [Full Text] [Related]
12. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
13. Increased consumption of wheat biofortified with selenium does not modify biomarkers of cancer risk, oxidative stress, or immune function in healthy Australian males.
Wu J; Salisbury C; Graham R; Lyons G; Fenech M
Environ Mol Mutagen; 2009 Jul; 50(6):489-501. PubMed ID: 19365873
[TBL] [Abstract][Full Text] [Related]
14. The influence of physiological and surgical menopause on coronary heart disease risk markers.
Verhoeven MO; van der Mooren MJ; Teerlink T; Verheijen RH; Scheffer PG; Kenemans P
Menopause; 2009; 16(1):37-49. PubMed ID: 18791484
[TBL] [Abstract][Full Text] [Related]
15. Coronary artery ectasia: is it a destructive inflammatory lesion of the vascular wall?
Turhan H; Yetkin E
Int J Cardiol; 2007 May; 118(2):241. PubMed ID: 16959337
[No Abstract] [Full Text] [Related]
16. The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?
Ridker PM
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1222-4. PubMed ID: 18565847
[No Abstract] [Full Text] [Related]
17. Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls.
Kop WJ; Weissman NJ; Zhu J; Bonsall RW; Doyle M; Stretch MR; Glaes SB; Krantz DS; Gottdiener JS; Tracy RP
Am J Cardiol; 2008 Mar; 101(6):767-73. PubMed ID: 18328837
[TBL] [Abstract][Full Text] [Related]
18. [Novel risk factors for cardiovascular disease and tobacco smoke].
Sobczak A; Szołtysek-Bołdys I; Zielińska-Danch W; Grela W; Gnyp W; Koszowski B
Przegl Lek; 2008; 65(10):715-8. PubMed ID: 19189586
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein concentrations are lower in Singaporeans: implications for risk classification in Asians.
Hawkins RC
Clin Chim Acta; 2004 Dec; 350(1-2):241-2. PubMed ID: 15530485
[No Abstract] [Full Text] [Related]
20. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
